• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.

Lymphocyte-specific protein tyrosine kinase (Lck) plays a key role in T cell signal transduction and is tightly regulated by phosphorylation and dephosphorylation. Lck can function as an oncoprotein when overexpressed or constantly activated by mutations. Our previous studies showed that Lck-induced cellular transformation could be suppressed by enforced expression of suppressor of cytokine signaling 1 (SOCS1), a SOCS family member involved in the negative feedback control of cytokine signaling. We observed attenuated Lck kinase activity in SOCS1-expressing cells, suggesting an important role of SOCS in regulating Lck functions. It remains largely unknown whether and how SOCS proteins interact with the oncogenic Lck kinase. Here, we report that among four SOCS family proteins, SOCS1, SOCS2, SOCS3 and CIS (cytokine-inducible SH2 domain containing protein), SOCS1 has the highest affinity in binding to the oncogenic Lck kinase. We identified the positive regulatory phosphotyrosine 394 residue in the kinase domain as the key interacting determinant in Lck. Additionally, the Lck kinase domain alone is sufficient to bind SOCS1. While the SH2 domain in SOCS1 is important in its association with the oncogenic Lck kinase, other functional domains may also contribute to overall binding affinity. These findings provide important mechanistic insights into the role of SOCS proteins as tumor suppressors in cells transformed by oncogenic protein tyrosine kinases.

Pubmed ID: 21234523


  • Venkitachalam S
  • Chueh FY
  • Leong KF
  • Pabich S
  • Yu CL


Oncology reports

Publication Data

March 24, 2011

Associated Grants

  • Agency: NCI NIH HHS, Id: CA107210
  • Agency: NCI NIH HHS, Id: R01 CA107210
  • Agency: NCI NIH HHS, Id: R01 CA107210-01A2
  • Agency: NCI NIH HHS, Id: R01 CA107210-02
  • Agency: NCI NIH HHS, Id: R01 CA107210-03
  • Agency: NCI NIH HHS, Id: R01 CA107210-04
  • Agency: NCI NIH HHS, Id: R01 CA107210-05
  • Agency: NCI NIH HHS, Id: R01 CA107210-06

Mesh Terms

  • Animals
  • COS Cells
  • Cercopithecus aethiops
  • Humans
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
  • Mutation
  • Oncogene Proteins
  • Phosphotransferases
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Protein Interaction Mapping
  • Suppressor of Cytokine Signaling Proteins
  • Transfection
  • Tyrosine